HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 

Gilead Sciences NEWS

NFE/5.0en-USnews-webmaster@google.com2018 Google Inc.Tue, 18 Dec 2018 05:22:31 GMTGoogle News
Gilead Sciences (GILD) Stock Moves -0.69%: What You Should Know  Zacks.com

Gilead Sciences (GILD) closed the most recent trading day at $65.12, moving -0.69% from the previous trading session.

Zacks.com
Did Gilead Sciences Make an $11 Billion Blunder?  Motley Fool

I read an interesting article recently about Gilead Sciences (NASDAQ:GILD). Bloomberg Opinion columnist Joe Nocera summarized Gilead's quest to market ...

Motley Fool
New Gilead Sciences CEO Has 'Breadth Of Experience' From Time At Roche, Says Bullish Raymond James  Yahoo Finance

O'Day joins Gilead after more than three decades of experience at Roche Holdings AG Basel ADR (OTC: RHHBY) with a focus on diagnostics, Raymond James' ...

Yahoo Finance
Gilead: The New CEO Will Need More Time  Seeking Alpha

Gilead recently announced the appointment of the new CEO, the current CEO of Roche Pharmaceuticals. There are multiple delays associated with the ...

Seeking Alpha
Gilead Sciences Gets A Much-Needed Confirmation Boost For Yescarta  Seeking Alpha

Gilead announced positive 2-year results treating patients with refractory large B-cell lymphoma after only a single infusion of Yescarta. At 2 years, 83% of pa.

Seeking Alpha
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know  Zacks.com

Gilead Sciences (GILD) closed at $67.49 in the latest trading session, marking a -0.97% move from the prior day.

Zacks.com
Better Buy: Gilead Sciences vs. Celgene  The Motley Fool

These big biotechs are due for a comeback. But which is likely to enjoy the biggest bounce?

The Motley Fool
Elon Musk, Carlos Ghosn, Huawei and Gilead Sciences - 5 Things You Must Know  TheStreet

U.S. stock futures turn mixed as investors continue to express concerns over the fate of U.S.-China trade talks; Tesla's Elon Musk says, 'I do not respect the SEC'; ...

TheStreet
Gets Its Catalyst And Trades Up:: Gilead Sciences, Inc., (NASDAQ: GILD)  StocksNewsPro

EPS is the portion of a company's profit allocated to each exceptional share of common accretion. EPS serves as a pointer of a company's profitability. EPS is ...

StocksNewsPro
Gilead Sciences, Inc. (GILD) Management Presents at The Evercore ISI HealthCONx Conference 2018 (Transcript)  Seeking Alpha

Gilead Sciences, Inc. (NASDAQ:GILD) Evercore ISI HealthCONx Conference November 27, 2018, 09:30 AM ET Executives Robin Washington - EVP & CFO ...

Seeking Alpha
Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 13, 2018  Nasdaq

Gilead Sciences, Inc. ( GILD ) will begin trading ex-dividend on December 13, 2018. A cash dividend payment of $0.57 per share is scheduled to be.

Nasdaq
BRIEF-Gilead Sciences Plans To Hire Daniel O'Day As Its Next CEO - WSJ  Reuters

Dec 9 (Reuters) -. * DRUGMAKER GILEAD SCIENCES PLANS TO HIRE DANIEL O'DAY AS ITS NEXT CEO - WSJ, CITING SOURCES Source text ...

Reuters
Life Sciences: Gilead Sciences — dedicated to making a real difference  Irish Examiner

In association with Gilead Sciences. Gilead Sciences is a leading biopharmaceutical company that discovers, develops and commercialises innovative ...

Irish Examiner
Where were the women in Gilead's CEO search? - San Francisco Business Times  San Francisco Business Times

Gilead's CEO search, Amyris' cannabis consideration and Principia's opportunity in this week's Health Care Digest.

San Francisco Business Times
Better Than All The Rest:: Gilead Sciences, Inc., (NASDAQ: GILD), Citizens Financial Group, Inc., (NYSE: CFG)  Global Export Lines

Earnings for each Share (EPS) are the part of a company's profit allocated to respectively outstanding share of common stock. EPS serves as a pointer to a ...

Global Export Lines
DOJ tells Supreme Court it has lost interest in its Gilead whistleblower case  FiercePharma

The Supreme Court had taken an interest in a Justice Department whistleblower case over whether Gilead Sciences lied to the FDA about using an unapproved ...

FiercePharma
Ex-Dividend Reminder: New Jersey Resources, Conmed and Gilead Sciences  Nasdaq

Looking at the universe of stocks we cover at Dividend Channel , on 12/13/18, New Jersey Resources Corp (Symbol: NJR), Conmed Corp. (Symbol: CNMD) ...

Nasdaq
Soaring beliefs: Gilead Sciences, Inc. (GILD), Walgreens Boots Alliance, Inc. (WBA)  FinBulletin

Gilead Sciences, Inc. (NASDAQ: GILD)'s stock value took a rollercoaster ride since the start of the recent year, with the year-to-date change of -6.07. Considering ...

FinBulletin
The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen  Nasdaq

For Immediate Release Chicago, IL - December 12, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks.

Nasdaq
Hot Stock Roundup — Gilead Sciences (GILD)  Stock News Stop

Gilead Sciences (GILD) lost -2.64% with the finishing price of $65.57 in Friday Trading Session. The stock price showed -26.77% negative in value from one ...

Stock News Stop
The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis  Nasdaq

For Immediate Release Chicago, IL - December 13, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks.

Nasdaq
Analysts predict the next Gilead CEO  Business Insider

BI Prime: The RBC Capital Markets analyst Brian Abrahams has identified some likely candidates who could replace CEO John Milligan.

Business Insider
Investors should know the success of Gilead Sciences, Inc. (GILD), Yum China Holdings, Inc. (YUMC)  NMSU Nеws

The shares of Gilead Sciences, Inc. (NASDAQ:GILD) went up during the trading session by $0.42 on Wednesday, trading at $68.14. At the moment, the company ...

NMSU Nеws
Can This Stock Rally? Weighted Alpha Reaches -16.50 For Gilead Sciences Inc (GILD)  LNR

Watching the levels on shares of Gilead Sciences Inc (GILD), we have noted that the beta research opinion is currently Sell. This signal uses a system.

LNR
Does Gilead Sciences Inc’s (NASDAQ:GILD) CEO Pay Reflect Performance?  Simply Wall St

John Milligan became the CEO of Gilead Sciences Inc (NASDAQ:GILD) in 2016. First, this article will compare CEO compensation with compensation at other ...

Simply Wall St
CAR-T Cells In The Real World  Seeking Alpha

Sales of Gilead's Yescarta should improve when hematologists know what it's for: in one survey of 162, over half (62%) did not. Estimated cost-effectiveness of.

Seeking Alpha
Gilead Sciences (GILD) Announces China's NMPA Approves Harvoni for Treatment of Chronic HCV Genotype 1-6  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Gilead Sciences, Inc. (NASDAQ: GILD) ...

StreetInsider.com
Gilead’s Vemlidy for chronic hepatitis B virus approved in China  Seeking Alpha

Gilead Sciences (GILD) announces that the China National Medical Products Administration ((NMPA)) has approved Vemlidy (tenofovir alafenamide, TAF) 25 ...

Seeking Alpha
Sell-Side Analysts Offering Perspectives on Gilead Sciences, Inc. (NASDAQ:GILD)  Hawthorn Caller

Wall street brokerage firm analysts are offering a consensus "Buy" rating on shares of Gilead Sciences, Inc. (NASDAQ:GILD). Using the following.

Hawthorn Caller
Gilead Sciences, Inc. (GILD34) Declined -5.59% on Dec 17  The FinExaminer

Shares of Gilead Sciences, Inc. (BVMF:GILD34) last traded at 128.18, representing a move of -5.59%, or -7.59 per share, on volume of 22600 shares. After.

The FinExaminer
Gilead Sciences : China Approves Descovy For Treatment Of HIV-1 Infection  Markets Insider

(RTTNews) - Gilead Sciences Inc. (GILD) announced that the China National Medical Products Administration or NMPA has approved Descovy ---emtricitabine ...

Markets Insider
Gilead Sciences, Inc. (NASDAQ:GILD) Growth in Question Despite -22.80% Analyst Projections  Steele Herald

Gilead Sciences, Inc. (NASDAQ:GILD) is expected to report earnings of -2.01% per share for next year, according to research firms covering the shares. Analysts ...

Steele Herald
How Far Can It Go? Gilead Sciences, Inc. (GILD)  NMSU Nеws

Barclays rated the Gilead Sciences, Inc. (NASDAQ:GILD)'s stock as an Overweight in a research note published on Friday, October 26th, 2018 and posted a $95 ...

NMSU Nеws
Gilead HIV Prevention Pill Gets Backing From U.S. Health Panel  Bloomberg

An influential U.S. health authority recommended an HIV prevention regimen using Gilead Sciences Inc.'s Truvada for people at high risk of getting the virus, ...

Bloomberg
Gilead Sciences, Inc. (NASDAQ:GILD) Could be Ripening for Opportunists  FDA Headlines

Gilead Sciences, Inc. (NASDAQ:GILD) has been in a severe correction. However, this period follows a dramatic bull market that saw the stock gain about 500% ...

FDA Headlines
You might find an opportunity to kick start again: Gilead Sciences, Inc. (GILD), Marathon Petroleum Corporation (MPC)  NMSU Nеws

MARTIN JOHN C, Director, sold 50,000 shares of the Gilead Sciences, Inc. (NASDAQ:GILD) in an exchange that happened on December 3rd, 2018. The stock ...

NMSU Nеws
Can A Similar Series of Events Expected At Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc. (SGYP)  Post Analyst

Gilead Sciences, Inc. (NASDAQ:GILD) enjoyed a weak run from the open in trading on 12/13/2018 with decreased volume coming into the shares and a close ...

Post Analyst
Gilead CAR-T therapy shows sustained benefit in treatment-resistant ALL patients  Seeking Alpha

Updated data from a Phase 1/2 clinical trial, ZUMA-3, evaluating Gilead Sciences' (GILD) CAR-T candidate KTE-X19 (formerly KTE-C19) in adult patients with.

Seeking Alpha
Deliciously Stocks: You should follow: Gilead Sciences, Inc. (NASDAQ:GILD), The Williams Companies, Inc. (NYSE:WMB), Viking Therapeutics, Inc. (NASDAQ:VKTX)  The Stock Street

Hot Stocks Alert: GILD, WMB, VKTX are discussed below. Gilead Sciences, Inc. (NASDAQ:GILD) has became attention seeker from the inquisitor when it ...

The Stock Street
When will the slump end? Gilead Sciences, Inc. (GILD), Dover Corporation (DOV)  NMSU Nеws

The shares of Gilead Sciences, Inc. (NASDAQ:GILD) went up during the trading session by $0.64 on Thursday, trading at $70.19. At the moment, the company ...

NMSU Nеws
Gilead's CAR-T Yescarta shows long-term benefit in lymphoma study  Seeking Alpha

Two-year data from the Phase 1/2 ZUMA-1 study evaluating Gilead Sciences' (GILD) Yescarta (axicabtagene ciloleucel) in patients with refractory large B-cel.

Seeking Alpha
Stocks - Apple, Boeing Slip in Premarket; Gilead Sciences, Tesla, Amazon Rise  Investing.com

Stocks - Apple, Boeing Slip in Premarket; Gilead Sciences, Tesla, Amazon Rise.

Investing.com
Wall Street Wants the Best Patents, Not the Best Drugs  Bloomberg

It's probably unfair to start a column about the new drugs that are curing Hepatitis C by referencing Jonas Salk and the discovery of the polio vaccine, but I'm ...

Bloomberg
Will these Ever Shine Again? Freeport-McMoRan Inc. (FCX), Gilead Sciences, Inc. (GILD)  NMSU Nеws

MATHER COURTNEY, Director, sold 75,000 shares of the Freeport-McMoRan Inc. (NYSE:FCX) in an exchange that happened on October 30th, 2018. The stock ...

NMSU Nеws
VIDEO: Gilead reports phase 2 safety, efficacy of GS-9674 for NASH  Healio

SAN FRANCISCO — In this exclusive video perspective from The Liver Meeting 2018, Rob Myers, MD, senior director of the liver diseases therapeutic area at ...

Healio
The Importance And The Opportunity: Gilead Sciences, Inc. (GILD), Bristol-Myers Squibb Company (BMY)  NMSU Nеws

MARTIN JOHN C, Director, sold 50,000 shares of the Gilead Sciences, Inc. (NASDAQ:GILD) in an exchange that happened on December 3rd, 2018. The stock ...

NMSU Nеws
Stocks That Fell to 3-Year Lows in the Week of Dec. 14  GuruFocus.com

Stocks That Fell to 3-Year Lows in the Week of Dec. 14, Stocks: GILD,T,BTI,LYG, release date:Dec 15, 2018.

GuruFocus.com
Mayo Investment Advisers Has Trimmed Its Gilead Sciences (GILD) Holding by $308,000 as Share Price Declined; As Cisco Sys (CSCO) Share Value Declined, Sheets Smith Wealth Management Has Increased Stake  The FinExaminer

Mayo Investment Advisers Llc decreased its stake in Gilead Sciences Inc (GILD) by 16.21% based on its latest 2018Q3 regulatory filing with the SEC.

The FinExaminer
Key turning points to Take off: Gilead Sciences, Inc. (GILD), Huntsman Corporation (HUN)  NMSU Nеws

The shares of Gilead Sciences, Inc. (NASDAQ:GILD) went down during the trading session by -$1.19 on Monday, trading at $68.01. At the moment, the company ...

NMSU Nеws
Petersen Flynn & Dinsmore Increases Holding in Kimberly Clark (KMB); Gilead Sciences (GILD) Shares Declined While Fukoku Mutual Life Insurance Company Has Lifted Stake  The FinExaminer

Petersen Flynn & Dinsmore Inc increased its stake in Kimberly Clark Corp (KMB) by 2.19% based on its latest 2018Q3 regulatory filing with the SEC. Petersen ...

The FinExaminer
Must be in your Portfolio: Agilent Technologies, Inc. (A), Gilead Sciences, Inc. (GILD)  NMSU Nеws

The shares of Agilent Technologies, Inc. (NYSE:A) went up during the trading session by $0.09 on Thursday, trading at $71.57. At the moment, the company has ...

NMSU Nеws
A better Deal: Sterling Bancorp (STL), Gilead Sciences, Inc. (GILD)  NMSU Nеws

The shares of Sterling Bancorp (NYSE:STL) went up during the trading session by $0.1 on Friday, trading at $18.64. At the moment, the company has a ...

NMSU Nеws
Gilead Sciences Com (GILD) Holding Maintained by Muhlenkamp & Co Inc; Jp Morgan Chase & Co (JPM) Shares Declined While Private Bank & Trust Co Has Increased Holding  The FinExaminer

Muhlenkamp & Co Inc increased its stake in Gilead Sciences Inc Com (GILD) by 6054.59% based on its latest 2018Q3 regulatory filing with the SEC.

The FinExaminer
Gilead Sciences to partner Tango Therapeutics on targeted oncology treatments pipeline  Zenopa

Gilead Sciences, Inc. and Tango Therapeutics, Inc. are in partnership to discover, develop, and commercialize a pipeline of targeted immuno-oncology therapies ...

Zenopa
Gilead Sciences (GILD) Shareholder Gmt Capital Decreased Stake as Stock Declined; Iowa State Bank Trimmed Its Otter Tail (OTTR) Position by $319,459  The FinExaminer

Gmt Capital Corp decreased its stake in Gilead Sciences Inc (GILD) by 55.27% based on its latest 2018Q3 regulatory filing with the SEC. Gmt Capital Corp sold ...

The FinExaminer
Highlighted Analyst Calls For Gilead Sciences, Inc. (GILD), Citizens Financial Group, Inc. (CFG)  Financial Mercury

Looking at top Wall Street opinions, Gilead Sciences, Inc. (NASDAQ: GILD) has recently made its way into the research list of Barclays – signaling that their ...

Financial Mercury
Gilead Sciences Announces Recipients of Asia Rainbow Grants Program  Markets Insider

Grants Program Supports Projects that Engage Young Adults and Communities Affected by HIV/AIDS -- -- Recipients Include Non-profit Organizations From Acr..

Markets Insider
Year-to-date (YTD) Evaluation: CVS Health Corporation (NYSE:CVS), Gilead Sciences, Inc. (NASDAQ:GILD)  Stocks News Point

CVS Health Corporation (NYSE:CVS)'s Analysis & Performances to Discover. On Friday, Shares of CVS Health Corporation flaunted -2.03% to reach at $71.88 ...

Stocks News Point
Analysts Observable Stock: Gilead Sciences, Inc. (GILD)  Nasdaq Click

Gilead Sciences, Inc. (GILD)'s stock fee update: Gilead Sciences, Inc. (GILD) inventory rate ended its day with loss -0.97% and finalized at the rate of $67.49, ...

Nasdaq Click
Wilder Moving Average Lower Than the Simple Moving Average for Gilead Sciences Inc. (GIS.DE)  Richland Standard

Monitoring the indicators on shares of Gilead Sciences Inc. (GIS.DE), we have spotted the 21 day Wilder Moving Average under the 50 day SMA . With this ...

Richland Standard
TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences  PRNewswire

CHAPEL HILL, N.C., Nov. 20, 2018 /PRNewswire/ -- TARGET PharmaSolutions, Inc., a company focused on real world evidence, is pleased to announce that it ...

PRNewswire
Global Pulmonary Arterial Hypertension (Pah) Medicine Market 2019: Pfizer, Gilead Sciences, Arena Pharmaceuticals, GlaxoSmithKline, Bayer HealthCare  Journal of Industry

Global Pulmonary Arterial Hypertension (Pah) Medicine Market has been brewing up and impacting the international economy in terms of growth rate, revenue, ...

Journal of Industry
Gilead Sciences Inc (GILD): What Are the Signals Showing?  Winslow Record

Investors might be looking to focus on some longer-term indicators on shares of Gilead Sciences Inc (GILD). The 100-day moving average verse price signal is.

Winslow Record
A Bit Overly Ripe For Owning: PayPal Holdings, Inc. (PYPL), Gilead Sciences, Inc. (GILD)  Post Analyst

PayPal Holdings, Inc. (NASDAQ:PYPL) popped in on a low volume green day. Volume on 11-Dec-18 came in at 8.07 million contracts. The daily trading volume ...

Post Analyst
Nothing In The Foreseeable Future Can Stop Gilead Sciences, Inc. (GILD), United Microelectronics Corporation (UMC)  The RNS Daily

Over the past 52 weeks Gilead Sciences, Inc. (NASDAQ:GILD) has embarked on a drop that has seen it decline -3.8% and is now up by 0.42% since start of this ...

The RNS Daily
GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers  Market Exclusive

GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; ...

Market Exclusive
Technical Secrets – Gilead Sciences (NASDAQ: GILD)  Alpha Beta Stock

Gilead Sciences (NASDAQ: GILD) stock encountered a rapid change of 0.34% in the last hour of Tuesday's trading session. The stock settled the final trade on ...

Alpha Beta Stock
Gilead Sciences hires Roche executive Daniel ODay as CEO  Business Standard

Read more about Gilead Sciences hires Roche executive Daniel O'Day as CEO on Business Standard. (Reuters) - Drugmaker Gilead Sciences Inc named ...

Business Standard
Is It Crazy To Buy Gilead Sciences, Inc. (GILD) And International Business Machines Corporation (IBM)?  Financial Mercury

The shares of Gilead Sciences, Inc. (NASDAQ:GILD) has been pegged with a rating of Overweight by Barclays in its latest research note that was published on ...

Financial Mercury
Stock Valuation: – Gilead Sciences, Inc., (NASDAQ: GILD)  Nyse NewsToday

The Relative Strength Index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or ...

Nyse NewsToday
Ride Out The Next Market Storm With Gilead Sciences, Inc. (GILD), Delta Air Lines, Inc. (DAL)  Financial Mercury

The shares of Gilead Sciences, Inc. (NASDAQ:GILD) has been pegged with a rating of Overweight by Barclays in its latest research note that was published on ...

Financial Mercury
Valuation Today:: Gilead Sciences, Inc., (NASDAQ: GILD)  Nyse Nasdaq News

Notable Technical and Performance analysis of the Gilead Sciences, Inc. stocks which belongs to US stocks Exchanges: ...

Nyse Nasdaq News
Noteworthy Analysts Suggestions: Gilead Sciences, Inc. (GILD)  Nasdaq Click

Gilead Sciences, Inc. (GILD) stock price ended its day with loss -2.91% and finalized at the price of $68.15, its 52 week- peak value and changed 6.04% from its ...

Nasdaq Click
Gilead Sciences teams with TARGET PharmaSolutions on liver studies  WRAL Tech Wire

Chapel Hill-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has formed a strategic partnership ...

WRAL Tech Wire
Stocks To Watch: Rite Aid Corporation (RAD) And Gilead Sciences, Inc. (GILD) In The Spotlight  GV Times

Rite Aid Corporation (NYSE:RAD) recorded -53.93% downtrend from the beginning of this year till date. The 12-month potential price target for Rite Aid ...

GV Times
LISTEN: Gilead's new boss & the year that was  STAT

In this episode of the podcast, we look back on 2018, digging into all the criminal chicanery, counter-intuitive goings on, and actual scientific progress.

STAT
The Drama Surrounding Dover Corporation (DOV), Gilead Sciences, Inc. (GILD)  The RNS Daily

A look at DOV technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 55.58 point. Its trading volume has lost ...

The RNS Daily
Why Dova Pharmaceuticals Is Nosediving Today  Motley Fool

After the company reported turnover in the executive suite and weak fourth-quarter results, shares of Dova Pharmaceuticals (NASDAQ:DOVA), ...

Motley Fool
Buy This And Sleep Well At Night:: Gilead Sciences, Inc., (NASDAQ: GILD)  StocksNewsPro

EPS is the portion of a company's profit allocated to each exceptional share of common accretion. EPS serves as a pointer of a company's profitability. EPS is ...

StocksNewsPro
Confluence Investment Management Has Lowered Gilead Sciences (GILD) Holding; Profile of 3 Analysts Covering MGM Resorts International (MGM)  The FinExaminer

Confluence Investment Management Llc decreased Gilead Sciences (GILD) stake by 2.08% reported in 2018Q3 SEC filing. Confluence Investment ...

The FinExaminer
New Research Coverage Highlights Skyworks Solutions, Virtus Investment Partners, Altria Group, Gilead Sciences, Arthur J. Gallagher, and BP plc — Consolidated Revenues, Company Growth, and Expectations for 2018  GlobeNewswire

NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest ...

GlobeNewswire
Stock alteration: – Gilead Sciences, Inc., (NASDAQ: GILD)  Nyse NewsToday

The Relative Strength Index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or ...

Nyse NewsToday
Kite Announces Updated Data From ZUMA-3 Study of KTE-X19 in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia  Business Wire

Kite, a Gilead Company (Nasdaq: GILD), announced updated results from ZUMA-3, a single-arm Phase 1/2 study evaluating KTE-X19 (formerly KTE-C19), an i.

Business Wire
ACTIVE Stock to Watch — Gilead Sciences (GILD)  Stock News Stop

Gilead Sciences (GILD) added 0.53% with the finishing price of $66.94 in Monday Trading Session. The stock price showed -25.24% down in value from one ...

Stock News Stop
Congo Ebola outbreak second largest in history  Seeking Alpha

The Ebola outbreak in eastern Congo is now the second biggest in history, with 426 confirmed and probable cases, resulting in 245 deaths since Aug. 1. Earl.

Seeking Alpha
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Compagnie Lombard Odier SCmA  Fairfield Current

Compagnie Lombard Odier SCmA raised its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 3.0% in the third quarter, according to its most recent ...

Fairfield Current
A straightforward reality behind these stocks: Synchrony Financial (SYF), Gilead Sciences, Inc. (GILD)  FinBulletin

Over the last 9-day stretch, shares of Synchrony Financial (NYSE: SYF) were observed to exhibit a Historic Volatility measurement of 25.87%. That figure, when ...

FinBulletin
Hot Stock Alert — Gilead Sciences (GILD)  Stock News Stop

Gilead Sciences (GILD) lost -1.23% with the finishing price of $66.74 in Thursday Trading Session. The stock price showed -25.46% negative in value from one ...

Stock News Stop
You Need to Know about stock? Gilead Sciences (GILD)  Connecting Investor

Let's consider Gilead Sciences (GILD) stock move that changed on Monday Dated DECEMBER 03, 2018. 11238486 shares changed at hands in last session ...

Connecting Investor
Gilead Sciences (GILD) Holder Cam Group Holding A Cut Stake by $2.53 Million as Valuation Declined; First Long Island Investors Has Increased Automatic Data Processing (ADP) Holding by $1.46 Million  EN Digest

Cam Group Holding A decreased its stake in Gilead Sciences Inc (GILD) by 13.37% based on its latest 2018Q3 regulatory filing with the SEC. Cam Group ...

EN Digest
Analysts Research Summary: Gilead Sciences Inc (GILD)Apps for PC Daily  AppsforPCdaily

Gilead Sciences Inc (NASDAQ:GILD) shares traded up 0.92% during most recent session. Wall Street analysts covering the stock are projecting that the stock ...

AppsforPCdaily
Gilead's (GILD) Harvoni and Descovy Get Approval in China  Zacks.com

Gilead's (GILD) HCV drug Harvoni and HIV cocktail therapy Descovy get approval in China.

Zacks.com
Does It Again, Another Green Light for Gilead Sciences, Inc. (GILD)  MONReport

Shares of Gilead Sciences, Inc. (NASDAQ:GILD) have generated a 1-year price change of -8.76%. However, a year is a very long time in the capital markets ...

MONReport
Gilead's Vemlidy Gets Approval in China for HBV Infection  Zacks.com

Gilead (GILD) obtains approval for Vemlidy in China for the treatment of chronic hepatitis B in adults and adolescents.

Zacks.com
Is It Right Time to Be Cautious on Gilead Sciences, Inc. (GILD), International Business Machines Corporation (IBM)?  Financial Mercury

The shares of Gilead Sciences, Inc. (NASDAQ:GILD) has been pegged with a rating of Overweight by Barclays in its latest research note that was published on ...

Financial Mercury
Gilead releases real-world data for hepatitis C treatment  Korea Biomedical Review

Gilead Science Korea said Tuesday that it has presented a large-scale real-world data (RWD) on the clinical efficacy of Harvoni (Ingredient: Sofosbuvir), ...

Korea Biomedical Review
A Deep Dive into the Insider Trading: Urban Outfitters, Inc. (URBN), Gilead Sciences, Inc. (GILD)  Financial Mercury

Looking at top Wall Street opinions, Urban Outfitters, Inc. (NASDAQ: URBN) has recently made its way into the research list of Telsey Advisory Group – signaling ...

Financial Mercury
Gilead Sciences, Inc. (GILD): Are There Still Some Opportunities On The Horizon  StockNewsGazette

Gilead Sciences, Inc. (NASDAQ:GILD) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a market value of ...

StockNewsGazette
Stock to Watch – Gilead Sciences (NASDAQ: GILD)  Stocks Pen

Gilead Sciences (NASDAQ: GILD) has a good repute in the Healthcare sector. But the most critical factor is that the company is coping with paradoxical condition ...

Stocks Pen
 

Gilead Sciences Videos

Gilead Sciences, Inc: A Commitment To Innovation
10:50:19
Gilead Sciences, Inc: A Commitment To Innovation
Gilead Sciences
17:59:12
Gilead Sciences
GILEAD ENVIRONMENT (FOSTER CITY)
06:16:42
GILEAD ENVIRONMENT (FOSTER CITY)
Gilead Sciences
22:23:52
Gilead Sciences
What's Gilead Sciences Doing With All That Cash?
17:39:09
What's Gilead Sciences Doing With All That Cash?
How can a single pill treat HIV? (Sponsored by Gilead)
14:00:02
How can a single pill treat HIV? (Sponsored by Gilead)
Dr. Michael Riordan Gilead Sciences founder, CEO Chairman interview 1994
14:21:11
Dr. Michael Riordan Gilead Sciences founder, CEO Chairman interview 1994
Gilead to Buy Kite for $11.9 Billion in Cancer Megadeal
17:27:59
Gilead to Buy Kite for $11.9 Billion in Cancer Megadeal
Gilead slashing prices of top-selling hepatitis C drugs
21:41:28
Gilead slashing prices of top-selling hepatitis C drugs
Options traders see more upside in Gilead
18:18:42
Options traders see more upside in Gilead
 

Gilead Sciences Images

Evolution Bioscience | The CAR-T Revolution: Gilead’s ...
Evolution Bioscience | The CAR-T Revolution: Gilead’s ...
Sofosbuvir-Velpatasvir Epclusa - Treatment - Hepatitis C ...
Sofosbuvir-Velpatasvir Epclusa - Treatment - Hepatitis C ...
Gilead HIV Eradication Program
Gilead HIV Eradication Program
EC grants marketing authorisation to Gilead's Genvoya for ...
EC grants marketing authorisation to Gilead's Genvoya for ...
Minéral 89 Hyaluronic Acid Gel Face Moisturizer | Vichy ...
Minéral 89 Hyaluronic Acid Gel Face Moisturizer | Vichy ...
Bringing Southern Grantees Together to Drive Progress ...
Bringing Southern Grantees Together to Drive Progress ...
HIV Dart/2016: Antiviral Activity of Tenofovir Alafenamide ...
HIV Dart/2016: Antiviral Activity of Tenofovir Alafenamide ...
Things you didn't know about Lindsay Shookus
Things you didn't know about Lindsay Shookus
Marriott logo | Hotel logo
Marriott logo | Hotel logo
AARP's Health Tools
AARP's Health Tools
 

Gilead Sciences WebSites

 

Gilead Sciences Wiki

Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead (also styled GILEAD), is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.